Art

J-GLOBAL ID：202002267716935095   Reference number：20A2372378

Bibliometric Study of Sodium Glucose Cotransporter 2 Inhibitors in Cardiovascular Research

心血管研究におけるナトリウムグルコース共輸送体2阻害剤の計量書誌学的研究【JST・京大機械翻訳】

Author (10)： Chen Lu (Department of Cardiology, State Key Laboratory of Organ Failure Research, Nanfang Hospital, Southern Medical University, Guangzhou, China) ,  Ma Siyuan (Department of Cardiology, State Key Laboratory of Organ Failure Research, Nanfang Hospital, Southern Medical University, Guangzhou, China) ,  Hu Donghong (Department of Cardiology, State Key Laboratory of Organ Failure Research, Nanfang Hospital, Southern Medical University, Guangzhou, China) ,  Lin Hairuo (Department of Cardiology, State Key Laboratory of Organ Failure Research, Nanfang Hospital, Southern Medical University, Guangzhou, China) ,  Zhu Yingqi (Department of Cardiology, State Key Laboratory of Organ Failure Research, Nanfang Hospital, Southern Medical University, Guangzhou, China) ,  Chen Kaitong (Department of Cardiology, State Key Laboratory of Organ Failure Research, Nanfang Hospital, Southern Medical University, Guangzhou, China) ,  Chen Lin (Department of Cardiology, State Key Laboratory of Organ Failure Research, Nanfang Hospital, Southern Medical University, Guangzhou, China) ,  Zheng Cankun (Department of Cardiology, State Key Laboratory of Organ Failure Research, Nanfang Hospital, Southern Medical University, Guangzhou, China) ,  Liu Jichen (Department of Cardiology, State Key Laboratory of Organ Failure Research, Nanfang Hospital, Southern Medical University, Guangzhou, China) ,  Liao Yulin (Department of Cardiology, State Key Laboratory of Organ Failure Research, Nanfang Hospital, Southern Medical University, Guangzhou, China)
Material： Frontiers in Pharmacology (Web)
Volume： 11  Page： 561494  Publication year： 2020 
JST Material Number： U7091A  ISSN： 1663-9812  Document type： Article
Article type： 原著論文  Country of issue： Switzerland (CHE)  Language： ENGLISH (EN)

Abstract/Point： Background: An increasing numb...

Register(free) or Log In to access     To see more with JDream III (charged).   {{ this.onShowAbsJLink("http://jdream3.com/lp/jglobal/index.html?docNo=20A2372378&from=J-GLOBAL&jstjournalNo=U7091A") }}

Thesaurus term： publications ,  keyword ,  thrust ,  hypoglycemic drug ,  diabetes mellitus ,  arteriosclerosis ,  visualization ,  cardiac insufficiency ,  obesity ,  clinical trial ,  *cardiovascular system ,  hot spot ,  bibliometrics ,  Web(information system)
Semi thesaurus term： 心血管イベント , 【Automatic Indexing@JST】

Author keywords (7)： sodium glucose co-transporter 2 inhibitors ,  bibliometrics ,  cardiovascular research ,  heart failure ,  publication trend ,  co-occurrence analysis ,  co-citation analysis

JST classification (2)： Basic research of drugs acting on carbohydrate metabolism  (GW13020Q) ,  Clinical application of drugs acting on carbohydrate metabolism  (GW13030B)

Reference (41)：

• AdingupuD. D.GöpelS. O.GrönrosJ.BehrendtM.SotakM.MiliotisT.. (2019). SGLT2 inhibition with empagliflozin improves coronary microvascular function and cardiac contractility in prediabetic ob/ob mice. Cardiovasc. Diabetol. 18 (1), 16. doi: doi: 10.1186/s12933-019-0820-6
• AI-JoboriH.DanieleG.CersosimoE.TriplittC.MehtaR.NortonL.. (2017). Empagliflozin and Kinetics of Renal Glucose Transport in Healthy Individuals and Individuals With Type 2 Diabetes. Diabetes 66 (7), 1999-2006. doi: doi: 10.2337/db17-0100
• AndreadouL.BellR. M.BøtkerH. E.ZuurbierC. J. (2020). SGLT2 inhibitors reduce infarct size in reperfused ischemic heart and improve cardiac function during ischemic episodes in preclinical models. Biochim. Biophys. Acta Mol. Basis Dis. 1866 (7), 165770. doi: doi: 10.1016/j.bbadis.2020.165770
• AnkerS. D.ButlerJ.FilippatosG. S.JamalW.SalsaliA.SchneeJ.. (2019). Evaluation of the effects of sodium-glucose co-transporter 2 inhibition with empagliflozin on morbidity and mortality in patients with chronic heart failure and a preserved ejection fraction: rationale for and design of the EMPEROR-Preserved Trial. Eur. J. Heart Fail. 21 (10), 1279-1287. doi: doi: 10.1002/ejhf.1596
• ArowM.WaldmanM.YadinD.NudelmanV.ShainbergA.AbrahamN. G.. (2020). Sodium-glucose cotransporter 2 inhibitor Dapagliflozin attenuates diabetic cardiomyopathy. Cardiovasc. Diabetol. 19 (1), 7. doi: doi: 10.1186/s12933-019-0980-4

Terms in the title (7)： 心血管 ,  研究 ,  ナトリウム ,  グルコース ,  共輸送体 ,  阻害剤 ,  計量書誌学